Earnings History Data for Arcturus Therapeutics Holdings Inc. (ARCT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as Alcobra Ltd, is based in San Diego, CA.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-03-2024	AH		ARCT	Arcturus Therapeutics Holdings Inc.	1,000.00	-0.32	-1.69	4.33	Arcturus Therapeutics GAAP EPS of -$0.32 beats by $0.54, revenue of $33.99M misses by $3.88M [3/7/2024 4:02 PM]	36.81	-0.38 (-1.02%)	35.75	-1.44 (-3.87%)	14.21 - 43.81	376,042	500,000	16,211
Arcturus Therapeutics GAAP EPS of -$0.32 beats by $0.54, revenue of $33.99M misses by $3.88M [3/7/2024 4:02 PM]
14-11-2023	AH		ARCT	Arcturus Therapeutics Holdings Inc.	509.63	-0.61	-1.79	-1.33	Arcturus Therapeutics GAAP EPS of -$0.61 beats by $1.04, revenue of $45.14M beats by $29.27M [11/14/2023 4:03 PM]	22.55	3.15 (16.24%)	22.93	3.53 (18.20%)	14.21 - 37.75	1,385,301	440,000	15,129
Arcturus Therapeutics GAAP EPS of -$0.61 beats by $1.04, revenue of $45.14M beats by $29.27M [11/14/2023 4:03 PM] Biggest stock movers today: Target, ZIM Integrated Shipping, JD.com, and more [11/15/2023 9:46 AM]
07-08-2023	AH		ARCT	Arcturus Therapeutics Holdings Inc.	870.47	-1.98	0.09	-0.82	Arcturus Therapeutics GAAP EPS of -$1.98 misses by $1.81, revenue of $10.52M misses by $38.81M [8/7/2023 4:17 PM]	25.69	-6.16 (-19.34%)	29.77	-2.08 (-6.53%)	13.02 - 37.75	1,148,967	390,000	682
Arcturus Therapeutics GAAP EPS of -$1.98 misses by $1.81, revenue of $10.52M misses by $38.81M [8/7/2023 4:17 PM] Arcturus down 18% on disappointing Q2 results [8/8/2023 12:17 PM]
09-05-2023	AH	4:00 PM ET (May 9)	ARCT	Arcturus Therapeutics Holdings Inc.	719.65	0.88	2.92	-1.94	Arcturus Therapeutics GAAP EPS of $1.87 beats by $1.46, revenue of $80.29M beats by $30.83M [5/9/2023 4:05 PM]	29.41	0.46 (1.59%)	29.99	1.04 (3.59%)	11.70 - 30.28	556,147	420,000	2,646
Arcturus Therapeutics GAAP EPS of $1.87 beats by $1.46, revenue of $80.29M beats by $30.83M [5/9/2023 4:05 PM]
28-03-2023	AH	4:00 PM ET (Mar 28)	ARCT	Arcturus Therapeutics Holdings Inc.	466.85	4.33	-1.86	-1.47	Arcturus Therapeutics EPS of $4.33, revenue of $160.29M beats by $79.77M [3/28/2023 4:02 PM]	20.14	4.64 (29.94%)	19.11	3.61 (23.29%)	11.70 - 31.41	4,454,779	270,000	229,241
Arcturus Therapeutics EPS of $4.33, revenue of $160.29M beats by $79.77M [3/28/2023 4:02 PM] Arcturus Therapeutics up 21% after hours on quarterly beats, cash runway extension [3/28/2023 6:08 PM]
09-11-2022	AH	4:00 PM ET (Nov 9)	ARCT	Arcturus Therapeutics Holdings Inc.	610.19	-1.33	-2.01	-2.05	Arcturus Therapeutics GAAP EPS of -$1.33 beats by $0.44, revenue of $13.4M beats by $9.31M [11/9/2022 4:03 PM]	19.45	-1.64 (-7.75%)	20.00	-1.09 (-5.17%)	11.70 - 48.75	1,078,110	950,000	19,817
Arcturus Therapeutics GAAP EPS of -$1.33 beats by $0.44, revenue of $13.4M beats by $9.31M [11/9/2022 4:03 PM] Arcturus downgraded at Baird on delayed catalyst and uncertainties in CSL deal [11/10/2022 2:21 PM] Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress [Nov-09-22 04:01PM]
09-08-2022	AH	4:00 PM ET (Aug 9)	ARCT	Arcturus Therapeutics Holdings Inc.	446.74	-0.82	-1.84	-2.07	Arcturus Therapeutics GAAP EPS of -$0.82 beats by $1.04, revenue of $27.09M beats by $24.58M [8/9/2022 4:04 PM]	17.48	-0.75 (-4.11%)	17.65	-0.58 (-3.18%)	11.70 - 65.00	512,975	410,000	4,131
Arcturus Therapeutics GAAP EPS of -$0.82 beats by $1.04, revenue of $27.09M beats by $24.58M [8/9/2022 4:04 PM] Arcturus Therapeutics downgraded to underperform at Raymond James on program setbacks [8/10/2022 8:54 AM] Arcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline Progress [Aug-09-22 04:00PM] Arcturus Therapeutics (ARCT) Reports Q2 Loss, Tops Revenue Estimates [Aug-09-22 05:15PM]
09-05-2022	AH	4:00 PM ET (May 9)	ARCT	Arcturus Therapeutics Holdings Inc.	532.78	-1.94	-1.29	-2.15	Arcturus Therapeutics GAAP EPS of -$1.94 misses by $0.63, revenue of $5.24M misses by $1.84M [5/9/2022 4:31 PM]	16.50	-0.11 (-0.66%)	16.00	-0.61 (-3.67%)	15.71 - 65.00	736,075	540,000	8,624
Arcturus Therapeutics GAAP EPS of -$1.94 misses by $0.63, revenue of $5.24M misses by $1.84M [5/9/2022 4:31 PM] Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress [May-09-22 04:00PM] Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates [May-09-22 05:15PM]
28-02-2022	AH	4:00 PM ET (Feb 28)	ARCT	Arcturus Therapeutics Holdings Inc.	611.56	-1.47	-1.77	-1.25	Arcturus Therapeutics GAAP EPS of -$1.47 beats by $0.16, revenue of $5.8M misses by $5.85M [2/28/2022 4:03 PM]	22.05	-1.92 (-8.03%)	22.60	-1.37 (-5.72%)	19.68 - 65.00	554,732	410,000	1,431
Arcturus Therapeutics GAAP EPS of -$1.47 beats by $0.16, revenue of $5.8M misses by $5.85M [2/28/2022 4:03 PM] Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress [Feb-28-22 04:00PM] Arcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates [Feb-28-22 05:15PM] Could Arcturus Therapeutics Be the Next Moderna? [Mar-01-22 11:00AM]
08-11-2021	AH	4:00 PM ET (Nov 8)	ARCT	Arcturus Therapeutics Holdings Inc.	1,180	-2.05	-1.40	-0.92	Arcturus Therapeutics EPS misses by $0.72, misses on revenue [11/8/2021 4:45 PM]	36.27	-2.38 (-6.16%)	37.10	-1.55 (-4.01%)	24.87 - 129.71	1,039,909	490,000	5,264
Arcturus Therapeutics EPS misses by $0.72, misses on revenue [11/8/2021 4:45 PM] Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress [Nov-08-21 04:00PM] Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates [Nov-08-21 05:35PM]
09-08-2021	AH	4:00 PM ET (Aug 9)	ARCT	Arcturus Therapeutics Holdings Inc.	824.09	-2.07	-1.99	-0.55	Arcturus Therapeutics EPS beats by $0.16, misses on revenue [8/9/2021 4:05 PM]	50.57	2.33 (4.83%)	58.61	10.37 (21.50%)	24.87 - 129.71	6,029,418	2,090,000	363,069
Arcturus Therapeutics EPS beats by $0.16, misses on revenue [8/9/2021 4:05 PM] Arcturus shares surge over 30% on cash runway update, Q2 results [8/10/2021 8:12 AM] Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress [Aug-09-21 04:01PM] Arcturus Therapeutics (ARCT) Reports Q2 Loss, Lags Revenue Estimates [Aug-09-21 05:25PM]
10-05-2021	AH	4:00 PM ET (May 10)	ARCT	Arcturus Therapeutics Holdings Inc.	945.56	-2.15	-1.16	-0.67	Arcturus Therapeutics EPS misses by $0.87, misses on revenue [5/10/2021 4:05 PM]	27.12	-1.78 (-6.17%)	26.80	-2.11 (-7.30%)	25.22 - 129.71	1,386,343	560,000	12,240
Arcturus Therapeutics EPS misses by $0.87, misses on revenue [5/10/2021 4:05 PM] Arcturus Therapeutics Holdings Inc to Host Earnings Call [May-10-21 02:30PM] Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data [May-10-21 04:01PM] Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates [May-10-21 08:05PM]
01-03-2021	AH	4:00 PM ET (Mar 1)	ARCT	Arcturus Therapeutics Holdings Inc.	1,640	-1.25	-0.90	-0.76	Arcturus Therapeutics EPS misses by $0.33, misses on revenue [3/1/2021 4:04 PM]	53.96	-0.68 (-1.24%)	53.50	-1.14 (-2.09%)	8.51 - 129.71	599,043	1,071,529	777
Arcturus Therapeutics EPS misses by $0.33, misses on revenue [3/1/2021 4:04 PM] Arcturus Therapeutics: Q4 Earnings Insights [Mar-01-21 05:26PM] Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates [Mar-01-21 04:01PM] Arcturus Therapeutics Holdings Inc to Host Earnings Call [Mar-01-21 02:30PM]
09-11-2020	AH	4:00 PM ET (Nov 9)	ARCT	Arcturus Therapeutics Holdings Inc.	1,500	-0.92	-0.47	-0.56	Arcturus Therapeutics EPS misses by $0.44, misses on revenue [11/9/2020 4:06 PM]	39.25	4.64 (13.41%)	37.25	2.64 (7.63%)	8.51 - 66.24	2,493,910	843,802	34,095

10-08-2020	AH	4:00 PM ET (Aug 10)	ARCT	Arcturus Therapeutics Holdings Inc.	1,370	-0.55	-0.53	-0.07	Arcturus Therapeutics EPS beats by $0.02, misses on revenue [8/10/2020 4:10 PM]	51.58	-7.33 (-12.44%)	58.77	-0.14 (-0.24%)	8.51 - 63.45	715,512	903,969	3,494